AUVI (AUVI) Stock Price & Analysis
AUVI (AUVI) rose 0.00% to USD 0 as of July 25, 2026 at 05:23 UTC, according to Nexqual real-time market data.
AUVI last closed at USD 0; the session ranged USD 0–0 on volume of 1,172 shares. Market capitalization is $1,402, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, July 25, 2026 at 05:23 UTC.
Key Statistics (as of July 25, 2026 at 05:23 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 1,172 shares |
| Market Cap | $1,402 |
| Exchange | PNK |
Technical Analysis (AUVI)
Nexqual's technical model rates AUVI "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of July 25, 2026 at 05:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (AUVI)
Wall Street analysts rate AUVI "None", per Nexqual as of July 25, 2026 at 05:23 UTC.
| Consensus Rating | None |
|---|
Earnings (AUVI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-03-31 | USD -35 vs est -33.75 ▼ miss |
| 2022-12-31 | USD -95 vs est -22.5 ▼ miss |
| 2022-09-30 | USD -30 vs est -22.5 ▼ miss |
| 2022-06-30 | USD -32.5 vs est -17.5 ▼ miss |
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Financials & Fundamentals (AUVI)
| Total Revenue | $40.72M |
|---|---|
| Revenue Growth (YoY) | +55.50% |
| Gross Margin | +19.22% |
| Operating Margin | -56.88% |
| Profit Margin | -32.43% |
| ROE | -62.70% |
| Debt / Equity | 31.41 |
| Current Ratio | 0.61 |
| Total Cash | $1.13M |
| Total Debt | $7.81M |
| Free Cash Flow | $7.16M |
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Financial Health Score (AUVI)
Nexqual rates AUVI's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 05:23 UTC.
| Growth | Strong — Revenue +73% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $1M cash vs $8M debt |
| Cash Flow | Strong — FCF $7M, 36% margin |
| Efficiency | Critical — ROE -63%, ROA -18.0% |
Ownership (AUVI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 4.67M |
| Float | 4.27M |
| Short % of Float | +1.94% |
Source: Nexqual, July 25, 2026 at 05:23 UTC.
Leadership (AUVI)
AUVI is led by Max Munn (age 79), Founder, CEO, President & Director, per Nexqual as of July 25, 2026 at 05:23 UTC.
| Founder, CEO, President & Director | Max Munn (age 79) |
|---|---|
| Senior VP, Compliance Officer & CFO | Michael Gerard Riccio (age 66) |
| Vice-President Global Sales | Robert Berger |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OLB | The OLB Group, Inc. | USD 0.31 | ▼ 6.37% |
| MEDS | DataMEDS AI, Inc. | USD 3.17 | ▼ 11.45% |
| GROM | Grom Social Enterprises, Inc. | USD 0 | ▲ 0% |
| DBGI | Digital Brands Group, Inc. | USD 12.9 | ▼ 35.63% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:23 UTC. This page is informational and not investment advice.